Overview

A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
A study to compare the plasma concentrations of MK0431 at different times in patients with hepatic insufficiency vs healthy control subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Sitagliptin Phosphate